CompoAtlas

Rejuveniix

Food supplement declared in France, declaration No 2018-3-347

Rejuveniix is a food supplement declared in France. Status: retiré du marché le 1 January 2024. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
ARIIX Europe B.V.
Status
Retiré du marché le 1 January 2024
Form
Gélule
Daily dose
2 gélules
Directions for use
Prendre 2 gélules par jour.
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Minceur / Modérateur d'appétit

Declaration 207022, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Euterpe oleracea Mart.FruitExtrait sec aqueux640 mg
Berberis vulgaris L.RacineExtrait sec hydroalcoolique50 mg
Moringa oleifera Lam.FeuilleExtrait sec aqueux50 mg
Adansonia digitata L.Fruit (pulpe)Poudre (de plantes séchées ou broyées)20 mg
Irvingia gabonensisGraine (endosperme)Poudre (de plantes séchées ou broyées)20 mg
Garcinia × mangostana L.FruitExtrait sec hydroalcoolique10 mg
Elaeagnus rhamnoides (L.) A.NelsonFruitPoudre (de plantes séchées ou broyées)10 mg
Lycium barbarum L.BaieExtrait sec hydroalcoolique10 mg
Crataegus laevigata (Poir.) DC.FruitExtrait sec hydroalcoolique5 mg
Matricaria chamomilla L.FleurDistillation3 mg

Other active ingredients

NamePer day
Caféinenot declared
Théaninenot declared
Son de riznot declared

Additives

E171, E555

Other ingredients

gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas utiliser pendant la grossesse. Ne pas administrer aux enfants de moins de 18 ans. Consultez votre médecin ou votre pharmacien en cas d’usage concomitant d’anticoagulants. Contient de la caféine, déconseillé aux enfants et aux femmes enceintes ou allaitantes et aux personnes sensibles à la caféine ( 47.5 mg/2 gélules).

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line